Since 2004, the government has been providing free Antiretroviral drugs (ARV) through ART centers to improve the survival and well-being of people living with HIV (PLHIV). In 2017, the NCASC adopted the WHO"s “Treat All” policy after updating the national HIV testing and treatment guidelines.

To support diagnosis and treatment, infrastructure such as CD4 and viral load testing machines has been established across the country, and healthcare personnel have been trained to deliver treatment, care, and support services effectively Since February 2017, Nepal has adopted the Test and Treat approach, guided by the National HIV Testing and Treatment Guidelines of 2022.

CD4 count services 161HIV AND STIS CONTROL AND MANAGEMENT PROGRAM are available at seven sites across seven districts and viral load testing sites has been expanded to nine sites. Multi-month dispensing (MMD) of ARV drugs have been practiced for clinically well clients with intention to mitigate the direct and indirect cost associated with both clients and service providers to improve care and retention in treatment. NCASC has systematically monitored and analysed the status of MMD among PLHIV using data recorded in HIV care and ART Tracking (DHIS2 Tracker, mHealth and Biometric) system. Additional, eLMIS has also been expanded to all ART sites to track the real time logistics status